Use of Amantadine in the Evaluation of Response to Chemotherapy in Lung Cancer: a Pilot Study

References

• YoungRC. Cancer statistics, 2002: progress or cause for concern?CA Cancer J. Clin.52(1), 6–7 (2002).
   PubMed Web of Science ®Google Scholar
• SmithRA , CokkinidesV , von EschenbachACet al.American Cancer Society guidelines for the early detection of cancer. CA Cancer J. Clin.52(1), 8–22 (2002).
   PubMed Web of Science ®Google Scholar
• HwangK-E , KimH-R. Response evaluation of chemotherapy for lung cancer. Tuberc. Respir. Dis.80, 136–142 (2017).
   PubMedGoogle Scholar
• WolchokJD , HoosA , O'DaySet al.Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin. Cancer Res.15, 7412–7420 (2009).
   PubMed Web of Science ®Google Scholar
• HoosA , EggermontAM , JanetzkiSet al.Improved endpoints for cancer immunotherapy trials. J. Natl Cancer Inst.102, 1388–1397 (2010).
   PubMed Web of Science ®Google Scholar
• ChiouVL , BurottoM. Pseudoprogression and immune-related response in solid tumors. J. Clin. Oncol.33, 3541–3543 (2015).
   PubMed Web of Science ®Google Scholar
• GettingerSN , HornL , GandhiLet al.Overall survival and long-term safety of nivolumab (anti-programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non-small-cell lung cancer. J. Clin. Oncol.33, 2004–2012 (2015).
   PubMed Web of Science ®Google Scholar
• BorghaeiH , Paz-AresL , HornLet al.Nivolumab versus docetaxel in advanced non squamous non-small-cell lung cancer. N. Engl. J. Med.373, 1627–1639 (2015).
   PubMed Web of Science ®Google Scholar
• KatzSI , HammerM , BagleySJet al.Radiologic pseudoprogression during anti-PD-1 therapy for advanced non-small-cell lung cancer. J. Thorac. Oncol.13(7), 978–986 (2018).
   PubMed Web of Science ®Google Scholar
• HochmairMJ , SchwabS , BurghuberOC , KrenbekD , ProschH. Symptomatic pseudo-progression followed by significant treatment response in two lung cancer patients treated with immunotherapy. Lung Cancer113, 4–6 (2017).
   PubMed Web of Science ®Google Scholar
• KongBY , MenziesAM , SaundersCABet al.Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy. Pigment Cell Melanoma Res.29(5), 572–577 (2016).
   PubMed Web of Science ®Google Scholar
• BrasAP , HoffHR , AokiFY , SitarDS. Amantadine acetylation may be affected by acetyltransferases other than NAT1 or NAT2. Can. J. Physiol. Pharmacol.76(7–8), 701–706 (1998).
   PubMed Web of Science ®Google Scholar
• BrasAP , JanneJ , PorterCW , SitarDS. Spermidine/spermine N(1)-acetyltransferase catalyzes amantadine acetylation. Drug Metab. Dispos.29(5), 676–680 (2001).
   PubMed Web of Science ®Google Scholar
• MaksymiukAW , SitarDS , AhmedRet al.Spermidine/spermine N1-acetyltransferase-1 (SSAT-1) as a diagnostic biomarker in human cancer. Future Sci. OA4(10), FSO345 (2018).
   PubMedGoogle Scholar
• SitarDS , BrasAP: US6,811,967B2B2 Method for assaying nonspermine/spermidine activity of spermidine/spermine N1-acetyltransferase (SSAT). (2004)
   Google Scholar
• MatsuiI , WiegandL , PeggAE. Properties of spermidine N-acetyltransferase from livers of rats treated with carbon tetrachloride and its role in the conversion of spermidine into putrescine. J. Biol. Chem.256(5), 2454–2459 (1981).
   PubMed Web of Science ®Google Scholar
• PeggAE , SeelyJE , PösöH , della RagioneF , ZagonIA. Polyamine biosynthesis and interconversion in rodent tissues. Fed. Proc.41(14), 3065–3072 (1982).
   PubMedGoogle Scholar
• SeilerN. Functions of polyamine acetylation. Can. J. Physiol. Pharmacol.65(10), 2024–2035 (1987).
   PubMed Web of Science ®Google Scholar
• BettuzziS , DavalliP , AstancolleSet al.Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. Cancer Res.60(1), 28–34 (2000).
   PubMed Web of Science ®Google Scholar
• RussellDH. Increased polyamine concentrations in the urine of human cancer patients. Nat. New Biol.233(39), 144–145 (1971).
   PubMedGoogle Scholar
• SuhJW , LeeSH , ChungBC , ParkJ. Urinary polyamine evaluation for effective diagnosis of various cancers. J. Chromatogr. B Biomed. Sci. Appl.688(2), 179–186 (1997).
   PubMedGoogle Scholar
• TakenoshitaS , MatsuzakiS , NakanoGet al.Selective elevation of the N1-acetylspermidine level in human colorectal adenocarcinomas. Cancer Res.44(2), 845–847 (1984).
   PubMed Web of Science ®Google Scholar
• KingsnorthAN , WallaceHM. Elevation of monoacetylated polyamines in human breast cancers. Eur. J. Cancer Clin. Oncol.21(9), 1057–1062 (1985).
   PubMedGoogle Scholar
• PineMJ , HubenRP , PeggAE. Production of N1-acetyl spermidine by renal cell tumors. J. Urol.141(3), 651–655 (1989).
   PubMed Web of Science ®Google Scholar
• SessaA , PerinA. Increased synthesis of N1-acetylspermidine in hepatic preneoplastic nodules and hepatomas. Cancer Lett.56(2), 159–163 (1991).
   PubMed Web of Science ®Google Scholar
• MaksymiukAW , TappiaPS , SitarDSet al.Use of amantadine as substrate for SSAT-1 activity as a reliable clinical diagnostic assay for breast and lung cancer. Future Sci. OA5(2), FSO365 (2018).
   PubMed Web of Science ®Google Scholar
• TappiaPS , MaksymiukAW , SitarDSet al.Predictive value and clinical significance of increased SSAT-1 activity in healthy adults. Future Sci. OA5(7), FSO400 (2019).
   PubMed Web of Science ®Google Scholar
• GoldbergSB , NarayanA , KoleAJet al.Early assessment of lung cancer immunotherapy response via circulating tumor DNA. Clin. Cancer Res.24(8), 1872–1880 (2018).
   PubMed Web of Science ®Google Scholar
• KhanM , LinJ , LiaoGet al.Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small-cell lung cancer. Medicine (Baltimore)97(33), e11936 (2018).
   PubMed Web of Science ®Google Scholar
• SchmidS , FruhM. Immune checkpoint inhibitors and small-cell lung cancer: what's new?J. Thorac. Dis.10(Suppl. 13), S1503–S1508 (2018).
   PubMedGoogle Scholar
• TrinidadLópez C , DeLa Fuente Aguado J , OcaPernas Ret al.Evaluation of response to conventional chemotherapy and radiotherapy by perfusion computed tomography in non-small-cell lung cancer (NSCLC). Eur. Radiol. Exp.3(1), 23 (2019).
   PubMedGoogle Scholar